Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1996;27:19-24

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Guan, H.
Right arrow Articles by Nasjletti, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guan, H.
Right arrow Articles by Nasjletti, A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*(L)-ARGININE
*LOSARTAN POTASSIUM
*NITRIC OXIDE
Medline Plus Health Information
*High Blood Pressure

(Hypertension. 1996;27:19-24.)
© 1996 American Heart Association, Inc.


Articles

Nitric Oxide and the Depressor Response to Angiotensin Blockade in Hypertension

Hui Guan; Victoria Cachofeiro; Michael L. Pucci; Pawel M. Kaminski; Michael S. Wolin; Alberto Nasjletti

From the Departments of Pharmacology and Physiology, New York Medical College, Valhalla, NY.

Abstract We investigated the contribution of nitric oxide to the short-term blood pressure reduction caused by interruption of the renin-angiotensin system in angiotensin-dependent hypertension. The blood pressure of rats made hypertensive by coarctation of the aorta between the renal arteries at their origin fell after administration of the angiotensin-converting enzyme inhibitor ramiprilat (2 mg/kg IV; -75±5 mm Hg) or the angiotensin II antagonist losartan (30 mg/kg IV; -79±6 mm Hg). But the antihypertensive effect of these agents was attenuated in rats pretreated with NG-nitro-L-arginine methyl ester (10 mg/kg IV) to inhibit nitric oxide synthesis (ramiprilat, -23±7 mm Hg; losartan, -37±5 mm Hg). In rats made hypertensive by long-term infusion of angiotensin II (60 ng/min IV, 6 to 7 days), the vasodepressor response to discontinuation of the angiotensin II infusion also was attenuated by pretreatment with the nitric oxide synthesis inhibitor (-52±7 versus -31±7 mm Hg); this attenuation was not demonstrable in rats receiving sodium nitroprusside (1 µg·kg -1·min -1 IV) to replace the loss of endogenous nitric oxide (-72±9 mm Hg). Pretreatment with NG-nitro-L-arginine methyl ester did not interfere with the vasodepressor effect of sodium nitroprusside or prazosin in rats with aortic coarctation–induced hypertension or with the blood pressure reduction caused by discontinuation of an infusion of phenylephrine in rats made hypertensive by long-term administration of this drug. These data suggest a contribution of nitric oxide to the blood pressure reduction caused by interruption of the renin-angiotensin system in models of established angiotensin-dependent hypertension.


Key Words: antihypertensive agents • experimental hypertension • losartan • nitric oxide • renin-angiotensin system • angiotensin-converting enzyme inhibitors




This article has been cited by other articles:


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
A. A Voors, P. P. van Geel, H. Buikema, M. Oosterga, D. J van Veldhuisen, and W. H van Gilst
High Angiotensin II Responsiveness is Associated with Decreased Endothelium-Dependent Relaxation in Human Arteries
Journal of Renin-Angiotensin-Aldosterone System, September 1, 2005; 6(3): 145 - 150.
[Abstract] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
Y. Quiroz, H. Pons, K. L. Gordon, J. Rincon, M. Chavez, G. Parra, J. Herrera-Acosta, D. Gomez-Garre, R. Largo, J. Egido, et al.
Mycophenolate mofetil prevents salt-sensitive hypertension resulting from nitric oxide synthesis inhibition
Am J Physiol Renal Physiol, July 1, 2001; 281(1): F38 - F47.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. Navalkar, S. Parthasarathy, N. Santanam, and B. V. Khan
Irbesartan, an angiotensin type 1 receptor inhibitor, regulates markers of inflammation in patients with premature atherosclerosis
J. Am. Coll. Cardiol., February 1, 2001; 37(2): 440 - 444.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
P. Gohlke, C. Pees, and T. Unger
AT2 Receptor Stimulation Increases Aortic Cyclic GMP in SHRSP by a Kinin-Dependent Mechanism
Hypertension, January 1, 1998; 31(1): 349 - 355.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. Maeso, J. Navarro-Cid, R. Munoz-Garcia, E. Rodrigo, L. M. Ruilope, V. Lahera, and V. Cachofeiro
Losartan Reduces Phenylephrine Constrictor Response in Aortic Rings From Spontaneously Hypertensive Rats: Role of Nitric Oxide and Angiotensin II Type 2 Receptors
Hypertension, December 1, 1996; 28(6): 967 - 972.
[Abstract] [Full Text]